Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 40,4x - 44,6x | 42,5x |
| Selected Fwd EBIT Multiple | -8,2x - -9,1x | -8,7x |
| Fair Value | ₩1.132 - ₩1.211 | ₩1.171 |
| Upside | -30,1% - -25,2% | -27,6% |
| Benchmarks | Ticker | Full Ticker |
| The Technology Co.,Ltd. | A043090 | KOSDAQ:A043090 |
| Celemics, Inc. | A331920 | KOSDAQ:A331920 |
| Hyundai ADM Bio Inc. | A187660 | KOSDAQ:A187660 |
| HLB bioStep Co.,Ltd. | A278650 | KOSDAQ:A278650 |
| NanoEntek, Inc. | A039860 | KOSDAQ:A039860 |
| Green Lifescience Co., Ltd. | A114450 | KOSDAQ:A114450 |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| A043090 | A331920 | A187660 | A278650 | A039860 | A114450 | ||
| KOSDAQ:A043090 | KOSDAQ:A331920 | KOSDAQ:A187660 | KOSDAQ:A278650 | KOSDAQ:A039860 | KOSDAQ:A114450 | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | NM- | NM- | NM- | NM- | -27.3% | -8.6% | |
| 3Y CAGR | NM- | NM- | NM- | NM- | -50.9% | NM- | |
| Latest Twelve Months | 47.9% | 67.0% | -737.0% | -999.9% | 127.9% | 108.1% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | -98.3% | -61.1% | -24.6% | 4.5% | 7.3% | -10.9% | |
| Prior Fiscal Year | -128.4% | -87.7% | -13.9% | -2.2% | -8.3% | -20.8% | |
| Latest Fiscal Year | -96.2% | -28.3% | -164.1% | -22.4% | 2.0% | 1.5% | |
| Latest Twelve Months | -96.2% | -28.3% | -164.1% | -22.4% | 2.0% | 1.5% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 0.50x | 2.21x | 7.15x | 1.60x | 2.52x | 0.97x | |
| EV / LTM EBITDA | -0.6x | -13.4x | -4.8x | -11.2x | 23.4x | 21.0x | |
| EV / LTM EBIT | -0.5x | -7.8x | -4.4x | -7.1x | 123.5x | 63.9x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -7.8x | -4.4x | 123.5x | ||||
| Historical EV / LTM EBIT | -250.8x | -21.5x | 63.9x | ||||
| Selected EV / LTM EBIT | 40.4x | 42.5x | 44.6x | ||||
| (x) LTM EBIT | 377 | 377 | 377 | ||||
| (=) Implied Enterprise Value | 15,217 | 16,018 | 16,819 | ||||
| (-) Non-shareholder Claims * | 7,513 | 7,513 | 7,513 | ||||
| (=) Equity Value | 22,731 | 23,532 | 24,333 | ||||
| (/) Shares Outstanding | 19.5 | 19.5 | 19.5 | ||||
| Implied Value Range | 1,164.12 | 1,205.14 | 1,246.15 | ||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 1,164.12 | 1,205.14 | 1,246.15 | 1,619.00 | |||
| Upside / (Downside) | -28.1% | -25.6% | -23.0% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | A043090 | A331920 | A187660 | A278650 | A039860 | A114450 | |
| Enterprise Value | 5,200 | (279) | 69,714 | 93,084 | 76,627 | 24,100 | |
| (+) Cash & Short Term Investments | 1,672 | 10,066 | 5,843 | 46,861 | 33,629 | 12,885 | |
| (+) Investments & Other | 3,381 | 15,141 | 2,041 | 37,687 | 27 | 0 | |
| (-) Debt | (5,696) | (518) | (9,288) | (34,696) | (466) | (5,372) | |
| (-) Other Liabilities | 163 | (0) | 194 | (4,940) | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 4,719 | 24,411 | 68,504 | 137,996 | 109,816 | 31,613 | |
| (/) Shares Outstanding | 12.4 | 8.2 | 42.3 | 84.2 | 32.1 | 19.5 | |
| Implied Stock Price | 380.00 | 2,990.00 | 1,620.00 | 1,639.00 | 3,420.00 | 1,619.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 380.00 | 2,990.00 | 1,620.00 | 1,639.00 | 3,420.00 | 1,619.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |